Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gross, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gross, M.
Related Collections
Right arrow Ethics
Right arrow Global Health
Right arrow Health Policy
Right arrow HIV/AIDS
Right arrow Other Statistics/Evaluation/Research
Right arrow Women's Health
November 2004, Vol 94, No. 11 | American Journal of Public Health 1846-1847
© 2004 American Public Health Association

LETTER

GROSS RESPONDS

Michael Gross, PhD

The author is an associate editor of the Journal and an independent consultant.

Correspondence: Requests for reprints should be sent to Michael Gross, PhD, 315 West 3rd St, No. 712, Long Beach, CA 90802 (email: m144@earthlink.net).

Because this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

The viewpoint of an expert as renowned as Stone—he received a lifetime achievement award at the international Microbicides 2004 conference for his leadership in the field—deserves careful consideration. As in his letter here, last spring Stone expressed a sense of urgency about proceeding forthwith to implement planned large-scale trials, irrespective of their impact on testing of new microbicide concepts: "Every day we’re not doing something, people are getting infected and dying . . . we’ve just got to get these products out there."1

Indeed we must, provided they do more good than harm. Stone knows that the notable outcome to . . . [Full Text]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Public Health Association